2018 was filled with a number of significant developments for healthcare marketers. The rising demand to respect individual privacy rights dominated conversations surrounding digital marketing, as did the increasing importance of using data-driven email marketing tools to increase physician engagement and retention.

Kala Pharmaceuticals Inc. announced that the New Drug Application (NDA) for KPI-121 0.25%, a product candidate for the temporary relief of signs and symptoms of dry eye disease utilizing a two-week course of therapy, has been accepted for review by the United States Food and Drug Administration FDA.

The U.S. Food and Drug Administration accepted for review Acer Therapeutics Inc.’s New Drug Application for Edsivo for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen mutation.

Opiant Pharmaceuticals Inc., a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced an exclusive global licensing agreement with Sanofi for the development and commercialization of drinabant for the treatment of acute cannabinoid overdose (ACO).

Global biopharmaceutical company AbbVie Inc. licensed pharma major Lupin Limited’s MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor program.

HCB Health hired veteran healthcare digital expert Colin Foster as chief digital officer to lead the healthcare communications agency’s flourishing digital practice.

AbbVie announced a new executive leadership team structure designed to streamline the company’s organizational structure and support its long-term growth strategy.

Celltrion Inc. and Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration approved Herzuma (trastuzumab-pkrb), a HER2/neu receptor antagonist biosimilar to Herceptin (trastuzumab).

Understanding the behaviors of our customers is central to the effectiveness of any ad campaign, and pharma is no different.

When it comes to advertising, 76 percent of primary care physicians (PCPs) prefer companies use simple language according to a survey conducted by GSW – a Syneos Health company and industry leader in healthcare advertising – in partnership with The Harris Poll.